Greene Barry E - Insider Non-Derivative Transactions at Sage Therapeutics, Inc. (SAGE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 31, 2025, Greene Barry E's relationship to Sage Therapeutics, Inc. (SAGE) is Director,Officer (President and CEO), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SAGE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Greene Barry E - Insider Non-Derivative Transactions of SAGE Common Stock

Greene Barry E - Insider Non-Derivative Transactions at SAGE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 1, 2025	U -- (Common Stock)	46940	0	0
Aug 1, 2025	Disposition -- (Common Stock)	53229	0	0
Apr 11, 2025	F -- (Common Stock)	4862	6.91	100169
Apr 11, 2025	Acquisition -- (Common Stock)	19964	0	105031
Aug 6, 2024	F -- (Common Stock)	12273	8.96	85067
Aug 6, 2024	Acquisition -- (Common Stock)	50400	0	97340